1 Impact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica.

2 Decreased Outpatient Fluoroquinolone Prescribing Using a Multimodal Antimicrobial Stewardship Initiative.

3 fluoroquinolone prophylaxis against febrile neutropenia in areas with high fluoroquinolone resistance—an asian perspective

4 design, synthesis and antitumor activity of c3/c3 bis-fluoroquonolones cross-linked with [1,2,4]triazolo[3,4-b] [1,3,4]thiadiazole

5 implementing precision antimicrobial therapy for the treatment of bovine respiratory disease: current limitations and perspectives

6 novel fluoroquinolone derivatives bearing n-thiomide linkage with 6-substituted-2-aminobenzothiazoles: synthesis and antibacterial evaluation

7 synthesis and antimalarial activity of novel dihydro-artemisinin derivatives

8 Quinolones and fluoroquinolones are useless to counter uropathogenic Escherichia coli infections [Letter]

9 Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

10 Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance

11 Alternations in DNA gyrase genes in low-level fluoroquinolone-resistant Moraxella catarrhalis strains isolated in Poland

12 Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance in Mycobacterium avium isolates

13 Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones

14 Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam

15 National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China

16 Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

17 Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

18 Quinolones and fluoroquinolones are useless to counter uropathogenic Escherichia coli infections [Letter]

19 Quinolones and fluoroquinolones are useless to counter uropathogenic Escherichia coli infections [Letter]

20 Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones

21 Inhibitory effects of fluoroquinolone antibiotics on Babesia divergens and Babesia microti, blood parasites of veterinary and zoonotic importance

22 Alternations in DNA gyrase genes in low-level fluoroquinolone-resistant Moraxella catarrhalis strains isolated in Poland

23 Single-nucleotide polymorphisms related to fluoroquinolone and aminoglycoside resistance in Mycobacterium avium isolates

24 Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones

25 Mutations in the gyrA, parC, and mexR genes provide functional insights into the fluoroquinolone-resistant Pseudomonas aeruginosa isolated in Vietnam

26 National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China

27 Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis

28 Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

29 Synthesis, in vitro Cytotoxicity and Trypanocidal Evaluation of Novel 1,3,6-Substituted Non-fluoroquinolones

30 Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones.

31 Removal of aqueous fluoroquinolones with multi-functional activated carbon (MFAC) derived from recycled long-root Eichhornia crassipes: batch and column studies.

32 Prevalence and Characterization of Fluoroquinolone Resistant Isolated From an Integrated Broiler Chicken Supply Chain.

33 Rapid and simultaneous determination of three fluoroquinolones in animal-derived foods using excitation-emission matrix fluorescence coupled with second-order calibration method

34 Fluoroquinolone-Resistant Salmonella enterica, Campylobacter spp., and Arcobacter butzleri from Local and Imported Poultry Meat in Kumasi, Ghana

35 SYNTHESIS AND ANTIMICROBIAL ACTIVITIES OF NEW 1,2,4- TRIAZOLES, MANNICH BASES, CONAZOLES, AND FLUOROQUINOLONES

36 Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities

37 A nanofiber mat prepared from sulfonated polyaniline for solid-phase extraction of fluoroquinolones from water and biological fluids prior to their quantitation by UPLC-MS/MS.

38 Rate constants of hydroxyl radicals reaction with different dissociation species of fluoroquinolones and sulfonamides: Combined experimental and QSAR studies

39 Clinical impact of rapid drug susceptibility testing to accompany fluoroquinolone-containing universal tuberculosis regimens: a Markov model.

40 Molecular characteristics, antimicrobial resistance profiles, and antibiotic resistance determinants in uropathogenic fluoroquinolone resistant-Escherichia coli isolates

41 The tcdA negative and tcdB positive Clostridium difficile ST81 clone exhibits high-level fluoroquinolone resistance: a multi-center study in Beijing, China.

42 Interaction of the fluoroquinolone antibiotic, ofloxacin, with titanium oxide nanoparticles in water: Adsorption and breakdown

43 Laboratory Survey of Fluoroquinolone Activity

44 Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France

45 Susceptibility of Antimicrobial-Resistant Urinary Escherichia coli Isolates to Fluoroquinolones and Nitrofurantoin

46 Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

47 Synergy of Fluoroquinolones with Other Antimicrobial Agents

48 Impact of Fluoroquinolones on the Gastrointestinal Flora

49 Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model

50 Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital

51 Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis

52 Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades

53 Factors influencing fluoroquinolone resistance

54 Application of fluoroquinolone pharmacodynamics

55 Evaluation of a successful fluoroquinolone restriction intervention among high-risk patients: A mixed-methods study

56 Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

57 Use of Fluoroquinolones for Intracellular Pathogens

58 Application of fluoroquinolone pharmacodynamics

59 Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance

60 Tendon or joint disorders in children after treatment with fluoroquinolones or azithromycin

61 fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems

62 adding gentamicin to fluoroquinolone-based antimicrobial prophylaxis reduces transrectal ultrasound-guided prostate biopsy-related infection rate

63 kinetic spectrophotometric method for the determination of some fourth generation fluoroquinolones in bulk and in pharmaceutical formulations

64 mutations in gyra & parc genes of shigella flexneri 2a determining the fluoroquinolone resistance

65 incidence of fluoroquinolone resistance in pseudomonas aeruginosa from urinary tract infections

66 determination of tetracycline and fluoroquinolone antibiotics at trace levels in sludge and soil

67 light and drugs: the photochemistry of fluoroquinolone antibiotics

68 fluoroquinolone resistance in non-multidrug-resistant tuberculosis—a surveillance study in new south wales, australia, and a review of global resistance rates

69 emergence of an extensively drug-resistant salmonella enterica serovar typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins

70 Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients

71 Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients

72 Low-Level Fluoroquinolone Resistance among Campylobacter jejuni Isolates in Australia

73 Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB

74 The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis

75 Antimicrobial Resistance in Invasive Non-typhoid Salmonella from the Democratic Republic of the Congo: Emergence of Decreased Fluoroquinolone Susceptibility and Extended-spectrum Beta Lactamases

76 Evaluation of genetic mutations associated with phenotypic resistance to Fluoroquinolones, Bedaquiline, and Linezolid in clinical Mycobacterium tuberculosis: A systematic review and meta-analysis.

Keyword Connections

Journals

Research Groups

Bibliographies